Platelet spreading and clot contraction are controlled by different pathways. This discovery leads to safer treatments for ...

The U.S. Food and Drug Administration (FDA) has announced the approval of Qfitlia (fitusiran), a treatment designed to ...

When skin is cut or damaged, tiny cell fragments circulating in the blood, called platelets, arrive at the injury and spread ...

Factor XI Inhibitors are the alternative to DOACs, which are highly effective at preventing strokes. However, their bleeding risks often limit their use, especially in high-risk patients.

Clotting is initiated by two processes or pathways - a slower but larger intrinsic pathway (contact activation pathway) or a very rapid extrinsic pathway (tissue factor pathway) - which lead to ...

Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last three years, the FDA has approved six new drugs for hemophilia. And now the U.

Updated results from the phase 3 XTEND-1 trial were presented at ISTH, once again comparing the therapy to patients' previous treatment with clotting factor replacement.

The anti-clotting effect of aspirin may trigger a biological chain of events that stops cancer cells from metastasizing, researchers say.

Disseminated intravascular coagulation is a bleeding disorder characterized by two seemingly opposite conditions. As a caregiver in a neonatal intensive care unit (NICU), it is not uncommon to ...

Until recently, researchers believed that platelet spreading and clot contraction were controlled by the same pathway. However a recent study from Thomas Jefferson University researchers challenges ...